Fig. 2From: Radiopharmacokinetic modelling and radiation dose assessment of 223Ra used for treatment of metastatic castration-resistant prostate cancerTime-dependent distribution of 223Ra in plasma, bone and colon after intravenous injection, as modelled for the present work. Patient data from [8, 10, 11, 17] are also shown with median values or values of mean ± SD. Bone indicates total bone, i.e. cortical and trabecular surface, volume and bone marrowBack to article page